US FDA Eases Informed Consent for Minimal Risk Clinical Trials

Us Fda To Waive Or Alter Elements Of Informed Consent For Certain Minimal Risk Clinical Trials
FDA Implements 21st Century Cures Act: Effective 30 days post-publication, ensuring rights and safety of human subjects. The final rule amendment allows exceptions for informed consent in minimal-risk clinical investigations.
Regulatory Intelligence Support

Have a
regulatory affairs

Regulatory Affair Icon